Insulet Corporation has grown revenue 28% a year over three years and 25% a year over five, with earnings per share compounding at 81%. Revenue growth, 3-year annual rate: +28% (Medical Devices median +9.2%). Revenue growth, 5-year rate: +25%, growth has picked up over the last three years. Earnings per share, 3-year rate: +81%, earnings outgrew revenue: margins or the share count worked for shareholders. Years of annual history on file: 17, FY2009 to FY2025, as filed.

PODDInsulet Corporation

HealthcareUSD

$143.36

$133.2152 weeks$352.82

Is it growing?

Is PODD growing?

Insulet Corporation has grown revenue 28% a year over three years and 25% a year over five, with earnings per share compounding at 81%.

+28%

Revenue growth, 3-year annual rate · Medical Devices median +9.2% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +25%
Revenue growth, 5-year rate · +28% over three · growth has picked up over the last three years
Earnings per share, 3-year rate: +81%
Earnings per share, 3-year rate · revenue +28% · earnings outgrew revenue: margins or the share count worked for shareholders
Years of annual history on file: 17
Years of annual history on file · FY2009 to FY2025, as filed